Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

Evolution of Heteroresistance

Objectif

Antibiotic resistance is a major threat to global health, associated with ≈ 5 million deaths annually. While the field has largely focused on the emergence of stable resistance through mutation or horizontal gene transfer, a critical evolutionary unstable intermediate remains underexplored: heteroresistance (HR). In HR, a rare subpopulation within a main susceptible bacterial population exhibits transient high-level resistance — a phenotype that enables survival and growth under antibiotic pressure and paves the way to stable resistance. HR is often caused by increased copy number of resistance genes with low expression or activity. While cells carrying a single gene copy are susceptible, those with elevated copy numbers become resistant, and can replicate under antibiotic exposure, potentially leading to treatment failure.
This project proposes a paradigm shift in our understanding of resistance evolution. Recent discoveries from our lab have revealed, across diverse bacterial pathogens, three novel and prevalent mechanisms by which HR emerges through increased gene copy number. These mechanisms generate subpopulations that evade antibiotic killing, yet revert rapidly in the absence of selection allowing the main population to remain fit. This duality makes HR an exceptionally flexible, but clinically dangerous, adaptive strategy. Despite its significance, the evolutionary origin(s) and consequences of HR remain unknown. This proposal seeks to fill that critical gap. We will (i) define the genetic and selective conditions that allow susceptible populations to evolve HR; (ii) determine how HR acts as a stepping stone toward stable resistance; and (iii) explore the potential of HR to promote horizontal gene transfer of resistance genes. By resolving these fundamental unknowns, this project will establish HR as a central driver in the evolution of antimicrobial resistance and inform future diagnostics and treatment strategies.

Champ scientifique (EuroSciVoc)

Programme(s)

Thème(s)

Régime de financement

HORIZON-ERC - HORIZON ERC Grants

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) ERC-2025-ADG

Voir tous les projets financés au titre de cet appel

Institution d’accueil

UPPSALA UNIVERSITET
Contribution nette de l'UE
€ 2 499 805,00
Adresse
VON KRAEMERS ALLE 4
751 05 Uppsala
Suède
Région
Östra Sverige Östra Mellansverige Uppsala län
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
Aucune donnée

Bénéficiaires (1)